2016 International Cord Blood Symposium
Registration is now open for the 14th International Cord Blood Symposium. Full conference registration is available along with individual daily registration for any attendee that is unable to participate in the full Symposium. Reserve your hotel room at the Hyatt Regency San Francisco which offers attendees an exclusive discounted rate.
The scientific program for the 14th International Cord Blood Symposium (ICBS) brings all of the umbilical cord blood related fields of hematopoietic stem cell transplantation, banking, and potential in regenerative medicine together in one interactive three day conference.
Building on its illustrious 13 year history, the program for this year’s ICBS has been expanded to include results of novel applications of cord blood derived immunotherapeutic approaches, more presentations from industry partners engaged in the commercialization of cellular therapies, the challenges faced by cord blood banks both in the US and internationally. The clinical transplantation and outcomes day includes a provocative debate on outcomes utilizing competing graft sources and the health economics of cord blood transplants. The best abstracts submitted to the conference will also be presented. World renowned experts in the cord blood field will deliver presentations during focused plenary sessions and workshops. The program also offers many networking opportunities.
1. Discuss the latest advances in cord blood transplantation and the challenges facing the cord blood banking industry including strategies to improve collection and quality and creating new business models.
2. Describe the impact of donor and recipient factors on outcomes of cord blood transplants.
3. Address the risks and benefits of different approaches for stem cell transplant recipients.
4. Assess the current market for commercialized cellular therapies and discuss the latest novel therapies in development for the treatment of non-hematologic diseases.
5. Learn about the latest advances in novel applications of cord blood and cord tissue derived therapies in the field of regenerative medicine.